Learn More
Invitrogen™ Cytomegalovirus p65 Monoclonal Antibody (CMV-224)

Description
Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, CMV is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of CMV disease. An indicator of active CMV infection is needed to facilitate the diagnosis of CMV disease in patients with AIDS or HIV infection. CMV p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.
Specifications
Specifications
| Antigen | Cytomegalovirus p65 |
| Applications | ELISA, Flow Cytometry, Immunohistochemistry (Frozen) |
| Classification | Monoclonal |
| Clone | CMV-224 |
| Concentration | 100 μg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% sodium azide |
| Gene Alias | CMV; CMV p65 |
| Host Species | Mouse |
| Immunogen | Recombinant CMV-p65 protein. |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.